Find the latest oncology news for your sub-specialty area
A CAR-T-cell therapy known as axicabtagene ciloleucel (axi-cel) is safe and shows encouraging signs of…
Hitting two targets at the same time may be the key to stopping the spread…
It is well-known exercise has many benefits, but new Edith Cowan University (ECU) research has revealed just…
Australian and New Zealand researchers have developed tiny metal ‘containing capsules’ for targeted delivery of…
Researchers from Children’s Hospital of Philadelphia (CHOP) in the USA have identified several genetic variants…
New research out of VCU Massey Cancer Center, USA, points to the inactivation of a…
Like the New York City subway system, the DNA in our cells needs to operate…
According to the results of the phase 1b MajesTEC-2 study, the immune-based triplet therapy regimen of teclistamab-cqyv, a…
In an early-phase trial, nearly three-quarters of patients who received talquetamab, a first-in-class experimental immunotherapy…
The International Atomic Energy Agency (IAEA) has joined forces with 11 of the largest professional…